Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD. - Wikidata - awgldk - TriplyDB

Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.

Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.

http://www.wikidata.org/entity/Q33774641

about

Organ-specific management and supportive care in chronic graft-versus-host disease.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review Myelodysplastic syndromes: toward a risk-adapted treatment approach.Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.A survey of infectious disease clinical practices among pediatric blood and marrow transplant programs in the United States.Antimicrobial prophylaxis in hematopoietic stem cell transplantation recipients: 10 years after.Foiling fungal disease post hematopoietic cell transplant: review of prophylactic strategies.

P2860

Q34270868-009E45E9-83CE-4724-ADDB-95CE2CD848A1 Q34532546-B99F250A-5BB0-4C3E-8CF1-2C828B71F102 Q35659502-00DDDD2E-42A8-4FA2-ACC4-DD8B6CA5F3C4 Q37866827-13A448CA-A56F-4486-812D-352B0474EDE3 Q38111391-055D8CDD-1717-404A-876F-AB2D21A6EEAA Q38149315-FC64571C-3A66-4FBE-A4D6-9FDB5970EC02 Q41441699-5C91CF6B-2DFE-411A-821B-56B63200B9AB Q41564706-CB5119CB-09AE-4B2E-8A2C-620D2E0C7549 Q42217316-8F384C91-96FC-484B-A1CA-3B3F2DAAC349 Q47882912-D0D622FE-7957-4CB1-9805-B74E0666D22E

P2860

Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.

http://www.wikidata.org/entity/Q33774641

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Voriconazole provides effectiv ...... ucocorticoid therapy for GVHD.

@ast

Voriconazole provides effectiv ...... ucocorticoid therapy for GVHD.

@en

type

label

Voriconazole provides effectiv ...... ucocorticoid therapy for GVHD.

@ast

Voriconazole provides effectiv ...... ucocorticoid therapy for GVHD.

@en

prefLabel

Voriconazole provides effectiv ...... ucocorticoid therapy for GVHD.

@ast

Voriconazole provides effectiv ...... ucocorticoid therapy for GVHD.

@en

P1433

Q33774641-546CB4ED-8C7F-43D3-83DF-6CA5990E938B

P1476

Q33774641-500E546F-E606-447C-82C3-0994C7B81481

P2093

Q33774641-010DD598-0C26-4240-8E82-CBD7E987003D

Q33774641-1CB4628E-58B2-4B81-B12C-F38DA6EFFD8B

Q33774641-450FB193-B015-4B0E-813E-0CA6B7F2BDCF

Q33774641-50371B6F-2F2D-45EA-B119-F9473BACDB42

Q33774641-5DECE3D6-4A0C-4804-9BBE-B4FF78D4BCC7

Q33774641-65E042A5-66D0-418A-A153-61A0250932DC

Q33774641-9420992C-5AEF-4D3C-A8F8-BAC5DC248064

Q33774641-B091FEBD-533A-475E-BF5D-2218A3795E15

Q33774641-C98C6681-1A86-46F8-BB7D-E00CBC78707D

Q33774641-EB0DC876-A1D7-439B-BB59-4B345C8EE897

P2860

Q33774641-28826C8B-86E5-4670-B68B-E8FDC5646B00

Q33774641-309240FE-D666-4369-BF25-365CE3512915

Q33774641-37802C65-7E1B-45FC-B6BB-68812EE10DEA

Q33774641-3F31B439-3181-46AB-B41A-B1EFB646F305

Q33774641-4B670E8E-533B-40D8-AFD8-9D736C00373D

Q33774641-54ABB194-6B7E-4E0E-BA89-29B6DC8B50C1

Q33774641-730EF8D9-DB56-4FB0-9920-C7F513CCDA5F

Q33774641-7AEEAE72-1412-4F9F-89C5-862C14CCAF57

Q33774641-AA2229F8-270B-475E-808C-C6AAAFE9979C

Q33774641-C6525EE0-65C6-49A9-A407-C3845E433D58

P2888

Q33774641-CDD6D8F5-064C-4B4D-8832-B5656EC07666

P304

Q33774641-AE6ABB85-AD0B-4198-979F-3C5193A6D654

P31

Q33774641-63FD1B64-61D5-498F-9324-3CE364F41A0F

P356

Q33774641-57FA886C-CE00-4B79-9BA1-93526A80EE14

P407

Q33774641-E0655C52-2E53-443C-899F-1BFFD1994FA9

P433

Q33774641-60E80E48-9A26-475F-BCBA-783639937E3A

P478

Q33774641-EDDEDBCB-8590-406A-8841-CD9D547931CB

P577

Q33774641-2C58D8CE-CE1F-4537-98FD-81F9C06B49A8

P5875

Q33774641-9C44F06D-92CC-4A11-BFE2-CA9F3DF6A6BF

P6179

Q33774641-2A9CB988-AF5D-44FE-81E8-78BB9FF033A8

P698

Q33774641-B306A291-7548-4128-BD2A-AC5A7139D0D0

P932

Q33774641-AB982936-2040-43FC-86E6-C3835A5052BE

P356

P1433

Bone Marrow Transplantation

P1476

Voriconazole provides effectiv ...... ucocorticoid therapy for GVHD.

@en

P2093

C Anasetti

http://www.w3.org/2001/XMLSchema#string

G Wetzstein

http://www.w3.org/2001/XMLSchema#string

J Greene

http://www.w3.org/2001/XMLSchema#string

J Perkins

http://www.w3.org/2001/XMLSchema#string

K Markey

http://www.w3.org/2001/XMLSchema#string

M J Schell

http://www.w3.org/2001/XMLSchema#string

M Kharfan-Dabaja

http://www.w3.org/2001/XMLSchema#string

T Field

http://www.w3.org/2001/XMLSchema#string

U Gergis

http://www.w3.org/2001/XMLSchema#string

Y Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation

In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp

Fungal infections after bone marrow transplant.

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation.

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.

Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.

P2888

P304

662-667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2009.210

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26745803

http://www.w3.org/2001/XMLSchema#string

P6179

1051314015

http://www.w3.org/2001/XMLSchema#string

P698

19684623

http://www.w3.org/2001/XMLSchema#string

P932

2850960

http://www.w3.org/2001/XMLSchema#string